TRIA Protein Solutions

TRIA Protein SolutionsTRIA Protein Solutions
TP

TRIA Protein Solutions

Developing novel protein-based materials for sustainable and high-performance applications.

DR 02021InactiveCambridge, United States
Rate

About

TRIA Protein Solutions is a startup focused on creating innovative protein-based materials. Their technology aims to provide sustainable alternatives to traditional materials, offering high performance for various applications. The company is developing solutions for industries seeking eco-friendly and advanced material options.
Frequently asked

What does TRIA Protein Solutions do?

TRIA Protein Solutions is a startup focused on creating innovative protein-based materials. Their technology aims to provide sustainable alternatives to traditional materials, offering high performance for various applications. The company is developing solutions for industries seeking eco-friendly and advanced material options.

What is TRIA Protein Solutions's revenue?

StartupHub estimates TRIA Protein Solutions's annual revenue at $23.5M (range $5.3M to $101.7M, 29% confidence), based on comparable companies in the sector.

What is TRIA Protein Solutions's valuation?

StartupHub estimates TRIA Protein Solutions's effective valuation at $362.9M (range $256.3M to $615.0M, 19% confidence), based on comparable companies in the sector.

How much funding has TRIA Protein Solutions raised?

TRIA Protein Solutions has raised a total of $103M in funding. The most recent round on record is Seed.

Where is TRIA Protein Solutions headquartered?

TRIA Protein Solutions is headquartered in Cambridge, United States.

When was TRIA Protein Solutions founded?

TRIA Protein Solutions was founded in 2021.

What industry does TRIA Protein Solutions operate in?

TRIA Protein Solutions operates in Biotech, Materials Science, Sustainable Materials, Protein Engineering, Advanced Manufacturing, Circular Economy.

What is TRIA Protein Solutions's current status?

TRIA Protein Solutions's current operating status is: Inactive.

Comments

No comments yet. Be the first to share your take.